PCM
Parsons Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Hold |
21,645
| – | – | 0.01% | 433 |
|
|
2025
Q1 | $76.6K | Hold |
21,645
| – | – | ﹤0.01% | 429 |
|
|
2024
Q4 | $81.8K | Sell |
21,645
-300
| -1% | -$1.13K | ﹤0.01% | 436 |
|
|
2024
Q3 | $71.1K | Hold |
21,945
| – | – | ﹤0.01% | 438 |
|
|
2024
Q2 | $41.7K | Hold |
21,945
| – | – | ﹤0.01% | 435 |
|
|
2024
Q1 | $62.3K | Hold |
21,945
| – | – | ﹤0.01% | 433 |
|
|
2023
Q4 | $323K | Hold |
21,945
| – | – | 0.02% | 363 |
|
|
2023
Q3 | $402K | Hold |
21,945
| – | – | 0.03% | 318 |
|
|
2023
Q2 | $473K | Hold |
21,945
| – | – | 0.04% | 303 |
|
|
2023
Q1 | $644K | Sell |
21,945
-5,200
| -19% | -$153K | 0.05% | 265 |
|
|
2022
Q4 | $1M | Buy |
27,145
+10,280
| +61% | +$380K | 0.08% | 202 |
|
|
2022
Q3 | $475K | Buy |
+16,865
| New | +$475K | 0.04% | 279 |
|